

Precision BioSciences (DTIL) trades up 10.55% premarket. Bullish moving averages and new data point to strong momentum.
You can purchase shares of Precision BioSciences (NASDAQ:DTIL) through any online brokerage.
Other companies in Precision BioSciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Precision BioSciences has a consensus price target of $37.17.
The stock price for Precision BioSciences (NASDAQ: DTIL) is $7.05 last updated October 23, 2026 at 8:38 AM EDT.
There are no upcoming dividends for Precision BioSciences.
Precision BioSciences does not have any upcoming earnings scheduled.
There is no upcoming split for Precision BioSciences.
Precision BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for...